Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
10/2009
10/15/2009CA2720613A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
10/14/2009EP1979360B1 Compounds and compositions as ppar modulators
10/14/2009EP1809639B1 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
10/14/2009EP1483269B1 Racemization and enantiomer separation of clopidogrel
10/14/2009CN101558075A 5- [4- (azetidin-3-yl0xy) -phenyl] -2-phenyl-5h-thiaz0l0 [5,4-c] pyridin-4-0ne derivatives and their use as mch receptor antagonists
10/14/2009CN101558069A Cis-cyclohexyl substituted pyrimidinone derivatives
10/14/2009CN100549007C Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors
10/14/2009CN100548296C Mitotic kinesin inhibitors
10/13/2009US7601846 Such as 2-(2-Imino-benzothiazol-3-yl)-1-(4-pyrrolidin-1-yl-phenyl)-ethanone hydrobromide salt, for protecting mammalian cells from damaging effects of chemotherapy, irradiation
10/13/2009CA2341678C Potassium channel inhibitors and method
10/08/2009WO2009123971A1 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
10/08/2009WO2009123536A1 NEW CLASSES OF GABAa/BZR LIGANDS
10/08/2009WO2009121872A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009WO2009121304A1 Preparation of ulifloxacin optical isomer
10/08/2009WO2009121303A1 Pharmaceutically acceptable salts of anti-infective quinolone compound
10/08/2009US20090253687 Fused Heterocyclic Compounds and Their Use as Mineralocorticoid Receptor Ligands
10/08/2009CA2720461A1 New classes of gabaa/bzr ligands
10/08/2009CA2720004A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009CA2719032A1 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
10/07/2009EP0741700B1 1-h-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents
10/07/2009CN101550153A Fluorine-containing optically active composition for anti-infection
10/06/2009US7598391 Heteroaryl-ureas and their use as glucokinase activators
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598266 Fused heterocyclic derivatives as PPAR modulators
10/06/2009US7598265 Compositions and methods for treating CNS disorders
10/06/2009US7598264 HIV integrase inhibitors
10/06/2009US7598254 Substituted 1,3-thiazolo[5,4-d]pyrimidines as xanthine oxidase inhibitors
10/06/2009US7598238 3-R-7-(phenylmethylene)-s-triazolo[3,4-b][1,3,4]-thiadiazine; fluorescent probes, antiproliferatives, anti-estrogenic, antimicrobial and antiviral agents; one-step, two-step syntheses; cancer; macular degeneration, psoriasis, arteriosclerosis or restenosis
10/06/2009US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators
10/01/2009WO2009121036A2 Substituted aryl pyrimidinone derivatives
10/01/2009WO2009120849A1 2-aryl- and 2-heteroarylthiazolyl compounds, methods for their preparation and use thereof
10/01/2009WO2009120140A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives 258
10/01/2009WO2009119710A1 Novel antibiotic sf2896 substance, process for production thereof, and pharmaceutical composition
10/01/2009WO2009079767A9 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
10/01/2009US20090247567 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
09/2009
09/30/2009EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses
09/30/2009EP2105435A1 Hydrazone derivative
09/30/2009CN101544664A 3a-(difluoromethyl)-3,3a-dihydrobenzene[d]pyrrole[2,1-b]thiazole-1(2H)-ketone and synthesis method thereof
09/30/2009CN101544663A 3a-(trifluoromethyl)-3,3a-dihydrobenzene[d]pyrrole[2,1-b]thiazole-1(2H)-ketone and synthesis method thereof
09/30/2009CN100545160C Diamine derivatives
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595313 Nitric oxide donating diuretic compounds, compositions and methods of use
09/24/2009US20090239882 Thiazolopyramidine Compounds for the Modulation of Chemokine Receptor Activity
09/24/2009US20090239857 Triamine derivative
09/24/2009CA2718035A1 Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
09/23/2009EP2103619A1 Imidazothiazole derivatives
09/23/2009CN101538268A Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
09/22/2009US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate
09/22/2009US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
09/22/2009US7592361 Indole acetic acid derivatives and their use as pharmaceutical agents
09/22/2009US7592354 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength
09/22/2009US7592352 e.g. 4-amino-3-(4-((2-fluoro-5-(trifluoromethyl)aminocarbonylamino)phenyl)-7-(3-chlorophenyl)-furo[3,2-c]pyridine; antiproliferative, anticarcinogenic, antitumor agent; solid tumor diseases, atherosclerosis, angiogenesis, vasculogenesis
09/22/2009US7592334 6-[({3-hydroxy-8-[6-(methyloxy)-1,5-naphthyridin-4-yl]-8-azaspiro[4.5]dec-2-yl}amino)methyl]-2H-pyrido[3,2-b][1,4]thiazin-3-on; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
09/22/2009US7592331 2-(1-Amino-isoquinolin-6-ylamino)-4,11-diazatricyclo[14.2.2.1(6,10)]henicosa-1(19),6,8,10(21),16(20),17-hexaene-3,12-dione trifluoroacetic acid salt; serine protease inhibitors; arterial cardiovascular thromboembolic disorders; cerebral, kidney, pulmonary embolisms; acute coronary syndrome;prosthetics
09/22/2009CA2145407C New reagents for peptide couplings
09/17/2009WO2009112565A1 Thiazolyl-dihydro-indazoles
09/17/2009WO2009080836A3 Macrocyclic indoles as hepatitis c virus inhibitors
09/17/2009US20090233919 Thiazolopyridinone derivates as mch receptor antagonists
09/17/2009DE102008014077A1 New borrelidin derivatives are janus kinase 3 inhibitors useful e.g. for treating tumor, microbial infection, immune disorder and ophthalmic disease, inhibiting angiogenesis, and manufacturing herbicides and insecticides against arthropods
09/17/2009CA2717488A1 Thiazolyl-dihydro-indazoles
09/17/2009CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
09/16/2009EP1910383B1 Benzodiazepine derivatives and uses thereof in medical field
09/16/2009EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/16/2009CN100540547C Inhibitors of histone deacetylase
09/15/2009US7589205 phosphodiesterase inhibitor; antiinflammatory agent; 3-thia-10-aza-phenanthrenes and iintermediates 3-(3,4-dialkoxy-phenyl)-tetrahydro-thiopyran-4-one and 3-(3,4-dialkoxy-phenyl)-1,1-dioxo-hexahydro-1-thiopyran-4-ylamine, useful for its preparation
09/15/2009US7589102 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/15/2009CA2274204C Spiro[piperidine-4,1'-pyrrolo[3,4-c]pyrrole]
09/11/2009WO2009026446A3 Hdac inhibitors
09/11/2009CA2625306A1 Electron acceptors-cored regioregular oligothiophenes as building blocks for soluble low band-gap conjugated polymers
09/10/2009US20090227789 Ethylenediamine derivatives
09/09/2009EP2097423A2 Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
09/09/2009EP2097421A2 Carbonic anhydrase inhibitors derivatives
09/09/2009EP1809284A4 Niacin receptor agonists, compositions containing such compounds and methods of treatment
09/09/2009EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
09/08/2009US7585867 Substituted thiazolo[4,5-d]pyrimidin-2(3H)-one
09/08/2009CA2316388C Tetrahydrobenzindole derivative
09/08/2009CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates
09/03/2009WO2009107850A2 Fused heterocyclic derivative and use thereof
09/03/2009US20090221762 Near infrared emissive fluorophores; Polymer band-gap reduction through augmentation of pi-backbone quinoidal character; (porphinato)(metal) moiety; ethynyl moiety; [1,2,5]thiadiazole or pentacenyl moiety; electronics, optics, emissive agents, treatment of disease, imaging, drug delivery; polymersomes
09/03/2009US20090221645 Dihydroimidazothiazole Derivatives
09/03/2009US20090221630 Iap inhibitors
09/03/2009CA2716773A1 Fused heterocyclic derivative and use thereof
09/02/2009EP2094714A2 Substituted thienopyridone compounds with antibacterial activity
09/02/2009EP2094704A2 Cis-cyclohexyl substituted pyrimidinone derivatives
09/02/2009EP2094690A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
09/02/2009EP2094685A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors
09/02/2009EP2094671A1 Heterobicyclic metalloprotease inhibitors
09/02/2009CN101522693A Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine deirvatives and their use in therapy
09/02/2009CN101522692A Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
09/01/2009US7582754 For treating hepatitis C virus infections; polymerase inhibitors
09/01/2009US7582752 Process for the resolution of nefopam
09/01/2009US7582652 Kinase inhibitors
09/01/2009US7582651 Pyrrolopyridine derivative and use thereof
09/01/2009CA2494528C Racemization and enantiomer separation of clopidogrel
08/2009
08/27/2009WO2009104819A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009WO2009104155A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/27/2009US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes
08/27/2009US20090215766 Tetracyclic inhibitors of janus kinases
08/27/2009US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid
08/27/2009CA2715872A1 Benzodiazepine compound and pharmaceutical composition
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 152